Skip to main content

Table 4 Disease characteristics according to sex, age, and disease categories in the JIA group

From: The patient’s voice: a cross-sectional study of physical health and disability in juvenile idiopathic arthritis

 

Na

CHAQ > 0

VAS pain > 0

PhysGA > 0

Not in remissionb

Sex, n (%)

 Female

131

84 (64.1)

87 (66.4)

47 (35.9)

118 (90.1)

 Male

90

44 (48.9)

52 (57.8)

28 (31.1)

74 (82.2)

Age group, n (%)

 < 9 years

46

29 (63.0)

22 (47.8)

12 (26.1)

42 (91.3)

 ≥ 9 years

175

99 (56.6)

117 (66.9)

63 (36.0)

150 (85.7)

Disease duration, n (%)

 < 5 years

122

78 (63.9)

86 (70.5)

48 (39.3)

110 (90.2)

 ≥ 5 years

99

50 (50.5)

53 (53.5)

27 (27.3)

82 (82.8)

Iso-BMIc, n (%)

 Underweight

15

5 (33.3)

9 (60.0)

7 (46.7)

12 (80.0)

 Normal

155

87 (56.1)

96 (61.9)

53 (34.2)

136 (87.7)

 Overweight/obese

51

36 (70.6)

34 (66.7)

15 (29.4)

44 (86.3)

JIA categoryd

 Oligoarticular persistent

76

36 (47.4)

46 (60.5)

23 (30.3)

56 (73.7)

 Oligoarticular extended

23

16 (69.6)

14 (60.9)

8 (34.8)

22 (95.7)

 Polyarticular RF negative

51

33 (64.7)

34 (66.7)

20 (39.2)

50 (98.0)

 Polyarticular RF positive

4

4 (100.0)

4 (100.0)

1 (25.0)

4 (100)

 Enthesitis-related arthritis

22

12 (54.6)

13 (59.1)

10 (45.5)

20 (90.9)

 Psoriatic arthritis

9

7 (77.8)

7 (77.8)

2 (22.2)

7 (77.8)

 Systemic

7

2 (28.6)

3 (42.9)

0 (0.0)

5 (71.4)

 Undifferentiated

29

18 (62.1)

18 (62.1)

11 (37.9)

28 (96.6)

  1. Abbreviations: N Number, CHAQ Childhood Health Assessment Questionnaire (0 = no physical disability, 3 = maximal physical disability), VAS pain Visual analogue scale for self-reported pain (0 = No pain, 10 = maximal pain) reported by the patient/parent on a 21-numbered circle VAS, PhysGA Physician's global assessment of disease activity (0 = No activity, 10 = high activity) reported by the physician on a 21-numbered circle VAS, RF Rheumatoid factor
  2. aNumber of participants assessed for each variable, excluding missing/unknown values. Total participants, N = 221
  3. bNot in remission = Patients who do not fit the criteria for “Remission off medication” (inactive disease off medication for >12 months) as defined by Wallace et al.
  4. cCalculated using the formula: Weight (kilograms)/[height (metres)]2 and subsequently adjusted for age and sex according to The International Obesity Task Force (IOTF) cut-off values to allow for comparison with adult BMI groups as defined by Cole TJ, et al.: Underweight: <18.5, normal weight: 18.5-24.9, overweight/obese: ≥25 kg/m2
  5. dCategories defined according to the International League of Association for Rheumatology (ILAR) classification criteria